Temporal relationship between increased nuchal translucency and enlarged jugular lymphatic sac

Obstetrics and Gynecology

Volumn 108, Issue 4, 2006, Pages 846-853

  Bekker, Mireille N ^a   Twisk, Jos W R ^b   Bartelings, Margot M ^b   Gittenberger De Groot, Adriana C ^b   Van Vugt, John M G ^b  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ANEUPLOIDY; ANGIOGENESIS; ARTICLE; AUTOPSY; CERVICAL LYMPH NODE; CONTROLLED STUDY; FEMALE; FETUS; GESTATIONAL AGE; HUMAN; LYMPHANGIOGENESIS; LYMPHATIC SYSTEM; MAJOR CLINICAL STUDY; NECK; NUCHAL TRANSLUCENCY MEASUREMENT; PREGNANCY TERMINATION; PRIORITY JOURNAL;

ABORTION, EUGENIC; ADULT; ANEUPLOIDY; FEMALE; GESTATIONAL AGE; HUMANS; LYMPHATIC VESSELS; NECK; NUCHAL TRANSLUCENCY MEASUREMENT; PREGNANCY; PREGNANCY TRIMESTER, FIRST; PREGNANCY TRIMESTER, SECOND; ULTRASONOGRAPHY, PRENATAL;

EID: 33749341153     PISSN: 00297844     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.AOG.0000238340.64966.81     Document Type: Article

References (30)

1. Pandya PP, Kondylios A, Hilbert L, Snijders RJ, Nicolaides KH. Chromosomal defects and outcome in 1015 fetuses with increased nuchal translucency. Ultrasound Obstet Gynecol 1995;5:15-9.
2. Snijders RJ, Noble P, Sebire N, Souka A, Nicolaides KH. UK multicentre project on assessment of risk of trisomy 21 by maternal age and fetal nuchal-translucency thickness at 10-14 weeks of gestation. Lancet 1998;352:343-6.
3. Hyett J, Moscoso G, Papapanagiotou G, Perdu M, Nicolaides KH. Abnormalities of the heart and great arteries in chromosomally normal fetuses with increased nuchal translucency thickness at 11-13 weeks of gestation. Ultrasound Obstet Gynecol 1996;7:245-50.
4. Bahado-Singh RO, Wapner R, Thom E, Zachary J, Platt L, Mahoney MJ, et al. Elevated first-trimester nuchal translucency increases the risk of congenital heart defects. Am J Obstet Gynecol 2005;192:1357-61.
5. Brady AF, Pandya PP, Yuksel B, Greenough A, Patton MA, Nicolaides KH. Outcome of chromosomally normal livebirths with increased fetal nuchal translucency at 10-14 weeks' gestation. J Med Genet 1998;35:222-4.
6. Montenegro N, Matias A, Areias JC, Castedo S, Barros H. Increased fetal nuchal translucency: possible involvement of early cardiac failure. Ultrasound Obstet Gynecol 1997;10:265-8.
7. Hyett J, Moscoso G, Nicolaides K. Abnormalities of the heart and great arteries in first trimester chromosomally abnormal fetuses. Am J Med Genet 1997;69:207-16.
8. von Kaisenberg CS, Krenn V, Ludwig M, Nicolaides KH, Brand-Saberi B. Morphological classification of nuchal skin in human fetuses with trisomy 21, 18, and 13 at 12-18 weeks and in a trisomy 16 mouse. Anat Embryol 1998;197:105-24.
9. von Kaisenberg CS, Prols F, Nicolaides KH, Maass N, Meinhold-Heerlein Brand-Saberi B. Glycosaminoglycans and proteoglycans in the skin of aneuploid fetuses with increased nuchal translucency. Hum Reprod 2003;18:2544-61.
10. von Kaisenberg CS, Nicolaides KH, Brand-Saberi B. Lymphatic vessel hypoplasia in fetuses with Turner syndrome. Hum Reprod 1999;14:823-6.
11. Haak MC, Bartelings MM, Jackson DG, Webb S, van Vugt JM, Gittenberger-de Groot AC. Increased nuchal translucency is associated with jugular lymphatic distension. Hum Reprod 2002;17:1086-92.
12. Bekker MN, Haak MC, Rekoert-Hollander Twisk JW, van Vugt JM. Increased nuchal translucency and distended jugular lymphatic sacs by first-trimester ultrasound. Ultrasound Obstet Gynecol 2005;25:239-45.
13. Gittenberger-De Groot AC, Van Den Akker NM, Bartelings MM, Webb S, van Vugt JM, Haak MC. Abnormal lymphatic development in trisomy 16 mouse embryos precedes nuchal edema. Dev Dyn 2004;230:378-84.
14. Achiron R, Yagel S, Weissman A, Lipitz S, Mashiach S, Goldman B. Fetal lateral neck cysts: early second-trimester transvaginal diagnosis, natural history and clinical significance. Ultrasound Obstet Gynecol 1995;6:396-9.
15. Chervenak FA, Isaacson G, Blakemore KJ, Breg WR, Hobbins JC, Berkowitz RL, et al. Fetal cystic hygroma: cause and natural history. N Engl J Med 1983;309:822-5.
16. Pandya PP, Snijders RJ, Johnson SP, De Lourdes Brizot M, Nicolaides KH. Screening for fetal trisomies by maternal age and fetal nuchal translucency thickness at 10 to 14 weeks of gestation. Br J Obstet Gynaecol 1995;102:957-62.
17. Goldstein H. Multilevel statistical models. London: Edward Arnold; 1995.
18. Pajkrt E, De Graaf IM, Mol BW, Van Lith JM, Bleker OP, Bilardo CM. Weekly nuchal translucency measurements in normal fetuses. Obstet Gynecol 1998;91:208-11.
19. Chitayat D, Kalousek DK, Bamforth JS. Lymphatic abnormalities in fetuses with posterior cervical cystic hygroma. Am J Med Genet 1989;33:352-6.
20. Van der Putte SC. Lymphatic malformation in human fetuses: a study of fetuses with Turner's syndrome or status Bonnevie-Ullrich. Virchows Arch A Pathol Anat Histol 1977;376:233-46.
21. Sebire NJ, D'Ercole C, Hughes K, Carvalho M, Nicolaides KH. Increased nuchal translucency thickness at 10-14 weeks of gestation as a predictor of severe twin-to-twin transfusion syndrome. Ultrasound Obstet Gynecol 1997;10:86-9.
22. Bekker MN, van den Akker NM, Bartelings MM, Arkesteijn JB, Fischer SG, Polman JA, et al. Nuchal edema and venous-lymphatic phenotype disturbance in human fetuses and mouse embryos with aneuploidy. J Soc Gynecol Investig 2006;13:209-16.
23. Haak MC, Twisk JW, Bartelings MM, Gittenberger-De Groot AC, van Vugt JM. First-trimester fetuses with increased nuchal translucency do not show changed intracardiac flow velocities. Ultrasound Obstet Gynecol 2005;25:246-52.
24. Stalmans I, Lambrechts D, De Smet F, Jansen S, Wang J, Maity S, et al. VEGF: a modifier of the del22q11 (DiGeorge) syndrome? Nat Med 2003;9:173-82.
25. Dumont DJ, Jussila L, Taipale J, Lymboussaki A, Mustonen T, Pajusola K, et al. Cardiovascular failure in mouse embryos deficient in VEGF receptor-3. Science 1998;282:946-9.
26. Liang D, Chang JR, Chin AJ, Smith A, Kelly C, Weinberg ES, et al. The role of vascular endothelial growth factor (VEGF) in vasculogenesis, angiogenesis, and hematopoiesis in zebrafish development. Mech. Dev 2001;108:29-43.
27. Dor Y, Klewer SE, McDonald JA, Keshet E, Camenisch TD. VEGF modulates early heart valve formation. Anat Rec A Discov Mol Cell Evol Biol 2003;271:202-8.
28. Bekker MN, Arkesteijn JB, Van Den Akker NM, Hoffman S, Webb S, van Vugt JM, et al. Increased NCAM expression and vascular development in trisomy 16 mouse embryos: relationship with nuchal translucency. Ped Res 2005;58:1222-7.
29. Miyabara S, Sugihara H, Maehara N, Shouno H, Tasaki H, Yoshida K, et al. Significance of cardiovascular malformations in cystic hygroma: a new interpretation of the pathogenesis. Am J Med Genet 1989;34:489-501.
30. Bohlandt S, von Kaisenberg CS, Wewetzer K, Christ B, Nicolaides KH, Brand-Saberi B. Hyaluronan in the nuchal skin of chromosomally abnormal fetuses. Hum Reprod 2000;15:1155-8.